Literature DB >> 32454634

Preparation and In Vitro Evaluation of Ibuprofen Spherical Agglomerates.

Nagaraju Ravouru1, Subhash Chandra Bose Penjuri2, Saritha Damineni3, Raja Lakshmi Muni1, Srikanth Reddy Poreddy2.   

Abstract

OBJECTIVES: Ibuprofen, an anti-inflammatory drug, is characterized by poor water solubility, which limits its pharmacologic effects. The present work aimed to the study the effect of agglomeration on the micromeritic properties and dissolution of ibuprofen.
MATERIALS AND METHODS: Ibuprofen agglomerates were prepared by solvent change method using water, dichloromethane and DMSO as poor solvent, bridging liquid and good solvent respectively in the ratio of 57.5:12.5:30. Process variables such as amount of bridging liquid, mode of addition, temperature and stirring rate were optimized.
RESULTS: SEM studies indicate that agglomerates produced were spherical and exhibit irregular shape. X-Ray Powder Diffraction spectra revealed the absence of polymorphism. DSC spectra showed no change in melting point indicating absence of crystal modification. The agglomerates exhibited improved solubility, dissolution rate and micromeritic properties compared to pure drug.
CONCLUSION: Anti-inflammatory studies were conducted in Wistar strain male albino rats and ibuprofen agglomerates showed more significant activity than the pure drug which may be due to better absorption. Ulcerogenic potential study was carried out for pure ibuprofen and agglomerates. Better ulcerogenic potential was observed in ibuprofen agglomerates treated rats. ©Copyright 2018 Turk J Pharm Sci, Published by Galenos Publishing House.

Entities:  

Keywords:  Ibuprofen; anti-inflammatory activity; spherical agglomeration; ulcerogenic potential

Year:  2018        PMID: 32454634      PMCID: PMC7227892          DOI: 10.4274/tjps.09609

Source DB:  PubMed          Journal:  Turk J Pharm Sci        ISSN: 1304-530X


  30 in total

1.  Effect of process variables on physicomechanical properties of the agglomerates obtained by spherical crystallization technique.

Authors:  Maryam Maghsoodi
Journal:  Pharm Dev Technol       Date:  2010-06-18       Impact factor: 3.133

2.  Evaluation of physico-mechanical properties of drug-excipients agglomerates obtained by crystallization.

Authors:  M Maghsoodi; A S Tajalli Bakhsh
Journal:  Pharm Dev Technol       Date:  2010-02-22       Impact factor: 3.133

3.  Improved bioavailability of aceclofenac from spherical agglomerates: development, in vitro and preclinical studies.

Authors:  S Muatlik; A N Usha; M S Reddy; A K Ranjith; S Pandey
Journal:  Pak J Pharm Sci       Date:  2007-07       Impact factor: 0.684

Review 4.  How spherical crystallization improves direct tableting properties: a review.

Authors:  Maryam Maghsoodi
Journal:  Adv Pharm Bull       Date:  2012-08-15

5.  Effect of binder liquid type on spherical crystallization.

Authors:  Maryam Maghsoodi; Ali Hajipour
Journal:  Drug Dev Ind Pharm       Date:  2013-08-13       Impact factor: 3.225

6.  Spherical crystal agglomeration of ibuprofen by the solvent-change technique in presence of methacrylic polymers.

Authors:  K Kachrimanis; I Nikolakakis; S Malamataris
Journal:  J Pharm Sci       Date:  2000-02       Impact factor: 3.534

7.  Preparation and evaluation of famotidine polymorphs.

Authors:  Ravouru Nagaraju; Ande Penchala Prathusha; Penjury Subhash Chandra Bose; Rajesh Kaza; Koganti Bharathi
Journal:  Curr Drug Discov Technol       Date:  2010-06

8.  On the mechanisms of formation of spherical agglomerates.

Authors:  Jyothi Thati; Ake C Rasmuson
Journal:  Eur J Pharm Sci       Date:  2011-01-07       Impact factor: 4.384

9.  Spherical crystallization of benzoic acid.

Authors:  Jyothi Katta; Ake C Rasmuson
Journal:  Int J Pharm       Date:  2007-07-10       Impact factor: 5.875

10.  Preparation of spherical crystal agglomerates of naproxen containing disintegrant for direct tablet making by spherical crystallization technique.

Authors:  A Nokhodchi; M Maghsoodi
Journal:  AAPS PharmSciTech       Date:  2008-01-09       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.